Depot Disulfiram for AIDS and ARC - Full Text View

Sponsored by:	St. Vincent's Medical Center
Information provided by:	NIH AIDS Clinical Trials Information Service
ClinicalTrials.gov Identifier:	NCT00002065

Purpose

To assess the safety and efficacy of depot disulfiram as a new treatment for AIDS and AIDS related complex.

Condition	Intervention
HIV Infections	Drug: Disulfiram

MedlinePlus related topics: AIDS

Drug Information available for: Disulfiram

Study Type:	Interventional
Study Design:	Treatment, Open Label
Official Title:	Depot Disulfiram for AIDS and ARC

Eligibility

Criteria

Inclusion Criteria

Patients must have a positive diagnosis of AIDS or AIDS related complex (ARC) according to the CDC criteria.

Also patient must be:
Able to understand the study.
Strongly motivated to participate in the study, and willing to comply with all the conditions specified in the informed consent forms.
Ambulatory and able to maintain an independent life outside the hospital.
Free of clinically significant organic disease affecting neurologic, hepatic, renal, and clinical status.

Patients must be free of clinically significant organic disease affecting neurologic, hepatic, renal, and clinical status.

History of alcohol abuse.

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00002065

Locations

United States, New York
Saint Vincent's Med Ctr
Staten Island, New York, United States, 10310

Sponsors and Collaborators

St. Vincent's Medical Center

More Information

Study ID Numbers:	024A
Study First Received:	November 2, 1999
Last Updated:	June 23, 2005
ClinicalTrials.gov Identifier:	NCT00002065
Health Authority:	United States: Food and Drug Administration

Keywords provided by NIH AIDS Clinical Trials Information Service:

Delayed-Action Preparations
Disulfiram
Acquired Immunodeficiency Syndrome
AIDS-Related Complex

Study placed in the following topic categories:

Disulfiram
Virus Diseases
Sexually Transmitted Diseases, Viral
HIV Infections
Sexually Transmitted Diseases

Acquired Immunodeficiency Syndrome
AIDS-Related Complex
Retroviridae Infections
Immunologic Deficiency Syndromes
Ethanol

Additional relevant MeSH terms:

RNA Virus Infections
Slow Virus Diseases
Molecular Mechanisms of Pharmacological Action
Immune System Diseases
Therapeutic Uses
Lentivirus Infections

Enzyme Inhibitors
Infection
Central Nervous System Agents
Pharmacologic Actions
Alcohol Deterrents

ClinicalTrials.gov processed this record on January 14, 2009